Gene Therapy: Bluebird’s Beti-Cel Sails Through US Panel Review On Strength of ‘Impressive’ Efficacy

 
• By Sue Sutter
Sailboat
Bluebird found smooth sailing for its beta-thalassemia gene therapy at a US FDA meeting. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers